Press release
Europe Biosimilars Market to Reach US$ 52.98 billion by 2033 | CAGR 27.7% | New Drug Approvals and Enhanced Market Access
Europe Biosimilars Market Size
New Drug Approvals of Biosimilars:
1. FDA approves Cyltezo (adalimumab-adbm) as a biosimilar for treatment of autoimmune diseases.
2. EMA grants approval for SB11 (ranibizumab biosimilar) for ocular conditions.
3. FDA clears Hulio (adalimumab-fkjp), a biosimilar for multiple inflammatory disorders.
4. EMA approves Truxima (rituximab biosimilar) for cancer and autoimmune therapies.
5. FDA authorizes Kanjinti (trastuzumab biosimilar) for HER2-positive breast cancer treatment.
6. EMA approves Ontruzant (trastuzumab biosimilar), expanding biosimilar options for oncology.
7. FDA grants approval to Nyvepria (pegfilgrastim biosimilar) for neutropenia prevention.
8. EMA authorizes Ruxience (rituximab biosimilar) for lymphoma and rheumatoid arthritis.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/europe-biosimilars-market?kb
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)
Latest M & A
• Biocon fully acquires Biocon Biologics, valuing the biosimilars unit at $5.5 B and consolidating it as a wholly‐owned subsidiary - strengthening its global biosimilars footprint, including Europe, and simplifying group structure.
• Viatris exits its equity stake in Biocon Biologics in an $815 M strategic transaction, allowing Biocon to consolidate full control and enabling Viatris to reset its biosimilars strategy globally.
• Sandoz Group AG completes acquisition of Just‐Evotec Biologics EU SAS (manufacturing & tech platform in Toulouse), including an asset plus an indefinite technology license to Evotec's continuous biologics manufacturing platform - reinforcing in‐house biosimilar development and manufacturing in Europe
Key Players:
Amgen Inc., Pfizer Inc., Sandoz Group AG, Teva Pharmaceuticals Inc., Biogen, Biocon Biologics Inc., Boehringer Ingelheim International GmbH, Samsung Biologics, Dr. Reddy's Laboratories Ltd and Fresenius Kabi AG.
Key Development:
January 2026
• EMA approves new biosimilar for rheumatoid arthritis, expanding treatment options.
• Leading pharma companies announce strategic partnerships to accelerate biosimilar R&D.
• Market adoption of oncology biosimilars sees significant growth in Western Europe.
December 2025
• Regulatory bodies update guidelines to streamline biosimilar approval processes.
• Surge in biosimilar launches in key European markets including Germany and France.
• Real-world data supports efficacy and safety of newly approved biosimilars.
November 2025
• Patent expirations of blockbuster biologics open avenues for biosimilar competition.
• Increased healthcare payer support boosts biosimilar reimbursement policies.
• Several biosimilar manufacturers announce capacity expansions to meet rising demand.
Growth Forecast Projected:
The Europe Biosimilars Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the Europe Biosimilars Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=europe-biosimilars-market?kb
Key Segments:
By Product Type: Monoclonal Antibodies, Recombinant Human Growth Hormone (rhGH), Insulin, Anti-coagulants, Erythropoietin, Granulocyte Colony Stimulating Factor, Follitropin Interferons, Others
By Application: Oncology, Chronic Diseases, Autoimmune Diseases, Infectious Diseases, Growth Hormone Deficiency, Hematology, Others
Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/europe-biosimilars-market?kb
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)
FAQ
Q1: What is the current size of the Europe Biosimilars Market?
A: The Europe Biosimilars Market was valued at US$ 5.96 billion in 2024 and is forecasted to reach US$ 52.98 billion by 2033
Q2: How rapidly will the Market expand?
A: The Europe Biosimilars market is projected to grow at a CAGR of 27.7% between 2025 and 2033.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?kb
Contact Us For Exclusive Information: https://www.datamintelligence.com/contact?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Biosimilars Market to Reach US$ 52.98 billion by 2033 | CAGR 27.7% | New Drug Approvals and Enhanced Market Access here
News-ID: 4370152 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Europe Functional Mushroom Market Harnesses Rare Species for Premium Health and …
DataM Intelligence has published a new research report on "Europe Functional Mushroom Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
Japan's Cloud ERP Market Outlook 2032 | Supports Data-Driven Decision Making Acr …
DataM Intelligence has published a new research report on "Japan Cloud ERP Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
Vietnam and Philippines Mechanical Ventilator Market at (CAGR 6.6%) | Tracks Pub …
DataM Intelligence has published a new research report on "Vietnam and Philippines Mechanical Ventilator Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of…
Europe Fermented Food and Beverages Market Builds on Heritage Foods with Modern …
DataM Intelligence has published a new research report on "Europe Fermented food and beverages Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of…
More Releases for Europe
2019 Strategy Consulting Market Analysis | McKinsey, The Boston Consulting Group …
Strategy Consulting Market reports also offer important insights which help the industry experts, product managers, CEOs, and business executives to draft their policies on various parameters including expansion, acquisition, and new product launch as well as analyzing and understanding the market trends
Need for strategic planning in highly competitive environment and to develop business capabilities to meet & exceed the emerging requirements are the major drivers which help in surging…
Strategy Consulting Market 2025 | Analysis By Top Key Players: Booz & Co. , Rola …
Global Strategy Consulting Market 2019-2025, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The key players covered in this study
McKinsey , The Boston Consulting Group , Bain & Company , Booz & Co. , Roland Berger Europe…
Digital Strategy Consulting Market is Thriving Worldwide with Deloitte, McKinsey …
A Digital Strategy is a form of strategic management and a business answer or response to a digital question, often best addressed as part of an overall business strategy. A digital strategy is often characterized by the application of new technologies to existing business activity and focus on the enablement of new digital capabilities to their business.
A new report as a Digital Strategy Consulting market that includes a comprehensive analysis…
Strategy Consulting Market 2019: By McKinsey, The Boston Consulting Group, Bain …
This report studies the global Strategy Consulting market, analyzes and researches the Strategy Consulting development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
• McKinsey
• The Boston Consulting Group
• Bain & Company
• Booz & Co.
• Roland Berger Europe
• Oliver Wyman Europe
• A.T. Kearney Europe
• Deloitte
• Accenture Europe
Get Sample Report@ https://www.reporthive.com/enquiry.php?id=1247388&req_type=smpl&utm_source=AB
Market segment by Type, the product can be split into
• Operations Consultants
• Business Strategy Consultants
• Investment Consultants
• Sales and…
Strategy Consulting Market Analysis 2018: McKinsey, The Boston Consulting Group, …
Orbis Research Present’s “Global Strategy Consulting Market” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage.
The global Strategy Consulting status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Strategy Consulting development in United States, Europe and China.
In 2017, the global Strategy Consulting market size was million US$ and it is expected to reach million…
Influenza Vaccination Market Global Forecast 2018-25 Estimated with Top Key Play …
UpMarketResearch published an exclusive report on “Influenza Vaccination market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Influenza Vaccination market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This…
